Avricore Health Inc. (TSXV:AVCR)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
0.00 (0.00%)
Sep 3, 2026, 1:40 PM EST

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of CAD 8.85 million. The enterprise value is 7.92 million.

Market Cap8.85M
Enterprise Value 7.92M

Important Dates

The next estimated earnings date is Wednesday, December 2, 2026.

Earnings Date Dec 2, 2026
Ex-Dividend Date n/a

Share Statistics

Avricore Health has 126.37 million shares outstanding. The number of shares has increased by 1.19% in one year.

Current Share Class 126.37M
Shares Outstanding 126.37M
Shares Change (YoY) +1.19%
Shares Change (QoQ) +3.54%
Owned by Insiders (%) 9.27%
Owned by Institutions (%) n/a
Float 114.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 45.82
PB Ratio 7.97
P/TBV Ratio 7.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 41.04
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.24

Current Ratio 8.24
Quick Ratio 7.40
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -132.03% and return on invested capital (ROIC) is -53.61%.

Return on Equity (ROE) -132.03%
Return on Assets (ROA) -50.37%
Return on Invested Capital (ROIC) -53.61%
Return on Capital Employed (ROCE) -105.55%
Weighted Average Cost of Capital (WACC) 6.00%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 26
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.32
52-Week Price Change n/a
50-Day Moving Average 0.06
200-Day Moving Average 0.06
Relative Strength Index (RSI) 53.87
Average Volume (20 Days) 57,624

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Avricore Health had revenue of CAD 193,041 and -1.80 million in losses. Loss per share was -0.02.

Revenue193,041
Gross Profit -69,301
Operating Income -1.17M
Pretax Income -1.80M
Net Income -1.80M
EBITDA -1.11M
EBIT -1.17M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 922,548 in cash and no debt, with a net cash position of 922,548 or 0.01 per share.

Cash & Cash Equivalents 922,548
Total Debt n/a
Net Cash 922,548
Net Cash Per Share 0.01
Equity (Book Value) 1.11M
Book Value Per Share 0.01
Working Capital 934,882
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.10 million and capital expenditures -22,946, giving a free cash flow of -1.13 million.

Operating Cash Flow -1.10M
Capital Expenditures -22,946
Depreciation & Amortization 62,487
Net Borrowing n/a
Free Cash Flow -1.13M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross Margin -35.90%
Operating Margin -606.69%
Pretax Margin -933.80%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.19%
Shareholder Yield -1.19%
Earnings Yield -20.38%
FCF Yield -12.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date Nov 21, 2016
Split Type Reverse
Split Ratio 0.25

Scores

Altman Z-Score n/a
Piotroski F-Score 1